01 March 2004
Reliability of the rapid bedside whole-blood quantitative cardiac troponin T assay in the diagnosis of myocardial injury in patients with acute coronary syndrome
Salam Saadeddin, Mohammed Habbab, Hisham Siddieg, Mahmoud Fayomi, Rofaida DafterdarMed Sci Monit 2004; 10(3): MT43-46 :: ID: 11602
Abstract
Background: A rapid bedside whole-blood quantitative cTnT assay has recently been developed. We evaluated
the reliability of this test for the diagnosis of myocardial injury in patients with acute coronary syndrome (ACS).
Material/Methods: Whole-blood cTnT levels were measured in 96 patients with ACS using the Roche Cardiac Reader[sup]®[/sup] rapid bedside assay device, and the results were compared with serum cTnT levels in the same patients measured by the Roche Elecsys[sup]®[/sup] Immunoanalyzer. There were 50 patients with clinical evidence of myocardial injury and 56 without.
Results: From the qualitative point of view (reporting negative or positive tests), the results of the rapid bedside tests were identical to those obtained by the serum immunoanalyzer. From
quantitative the point of view, the rapid bedside tests could not measure exact values below
0.1 ng/ml (reported negative) or above 2.0 ng/ml (reported >2.0). The measurements made by the rapid bedside tests within the range of 0.1 to 2.0 ng/ml correlated well with those of the serum immunoanalyzer (Cardiac Reader[sup]®[/sup] cTnT=0.61, Elecsys[sup]®[/sup] cTnT+0.12; r=0.88), but their mean values were significantly lower (1.20±0.71 vs. 1.41±1.03, p=0.0007).
Conclusions: The rapid bedside cTnT assay correlates well with immunoanalyzer measurements between
the values of 0.1 and 2.0 ng/ml. However, they tend to give significantly lower values and fail
to give exact values below 0.1 and above 2.0 ng/ml, which may affect their performance in monitoring and managing patients with ACS, and limit their use in predicting outcome.
Keywords: Coronary Arteriosclerosis - diagnosis, Dose-Response Relationship, Drug, Heart Diseases - diagnosis, Heart Injuries - diagnosis, Immunoassay - instrumentation, Immunoassay - methods, Myocardium - metabolism, Reagent Kits, Diagnostic, Reproducibility of Results, Sensitivity and Specificity, Troponin I - blood, Troponin T - blood, Coronary Artery Disease - diagnosis, Dose-Response Relationship, Drug, Heart Diseases - diagnosis, Heart Injuries - diagnosis, Immunoassay - methods, Myocardium - metabolism, Reagent Kits, Diagnostic, Reproducibility of Results, Sensitivity and Specificity, Troponin I - blood, Troponin T - blood
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952